Reversal of multidrug resistance in Vivo by dietary administration of the phytochemical indole-3-carbinol 1

Cancer Research

Volumn 56, Issue 3, 1996, Pages 574-581

  Christensen, James G ^a   LeBlanc, Gerald A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; AZIDOPINE; CISPLATIN; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; MEMBRANE PROTEIN; TRITIUM; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DIETARY INTAKE; MELANOMA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; AZIDES; DIHYDROPYRIDINES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INDOLES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; MICE, NUDE; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; PHENOTYPE; TRANSFECTION; TRITIUM;

EID: 0030041159     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Goldstein, L J , Galski, H., Fojo, A., Wilingham, M , Lai, A., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M , Cossman, J , Gottesman, M. M., and Pastan, I. Expression of multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
2. Sanfilippo, O , Ronchi, E., DeMarco, C., DiFronzo, G., and Silvestrini, R. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxirubicin and vincristine. Eur. J. Cancer, 27: 155-158, 1991.
3. Roninson, I. B. The role of MDR-1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol., 43: 95-102, 1992.
4. Kartner, N , Riordan, J. R., and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Washington DC), 221: 1285-1288, 1983.
5. Endicott, J A., and Ling, V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
6. Slovak, M. L., Hoeltge, G. E., Dalton, W. S., and Trent, J. M. Expression of glutathione-S-transferases confer the MDR phenotype to cells. Cancer Res., 48: 2793-2797, 1988.
7. Beck, W. T., Cirtain, M. C , Danks, M. K , Felsted, R. L., Safa, A. R., Wolverton, J. S., Suttle, D. P., and Trent, J. M. Resistance of mammalian cell lines to anticancer drugs due to overexpression of GSTs. Cancer Res , 47: 5455-5460, 1987.
8. Fan, S., el Deiry, W. S., Bas, I , Freeman, J , Jondle, D., Bhatia, K , Fornace, A. J J , Magrath, I., Kohn, K., and O' Connor, P. M p53 gene mutation associated with decreased sensitivity of lymphoma cells to DNA damaging agents. Cancer Res , 54: 5824-5830, 1994.
9. Cabral, F , Sobel, M E., and Gottesman, M. M. Topoisomerase II mutations that confer the multidrug resistance phenotype on human cancer cells. Cell, 20. 29-36, 1980.
10. Gros, P., Ben Neriah, F., Croop, J. M. L., and Housman, D. E. Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature (Lond.), 323: 728-731, 1986
11. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of a full length cDNA for the human MDR-1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
12. Gottesman, M. M. How cancer cells evade chemotherapy. Cancer Res., 53: 747-754, 1993
13. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem , 62: 385-427, 1993.
14. Pastan, I., and Gottesman, M. M. Multiple drug resistance in human cancer. N. Engl. J. Med., 316: 385-427, 1993.
15. Thiebaut, F , Tsuruo, T , Hamada, H., Gottesman, M. M., Pastan, I., and Willingharn, M. C. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA, 84: 7735-7738, 1987.
16. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein, P170: evidence for localization in brain capillaries and and cross-reactivity of one antibody with a muscle protein. J. Histochem. Cytochem., 37: 159-164, 1989
17. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y. Increased accumulation of vincristine and doxorubicin in drug resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res., 42: 4730-4733, 1982.
18. Inaba, M., Fujikara, R., Tsukagoshi, S., and Sukurai, Y. Restored in vitro sensitivity of doxorubicin and vincristine resistant P388 leukemia cells with reserpine Biochem. Pharmacol, 30: 2191-2194, 1981.
19. Twentyman, P. R , Fox, N. E , and White, D. J. G. Cyclosporine A and its analogues as modifiers of doxorubicin and vincristine resistance in a multidrug resistant human cancer cell line Br. J. Cancer, 56: 55-60, 1987.
20. McDanell, R., McLean, A. E. M , Hanley, A. B., Heaney, R K , and Fenwick, G R. Chemical and biological properties of indole glucosinates (glucobrassicins): a review Food Chem. Toxicol., 26, 59-70, 1986
21. DeKruif, C. A., Marsman, J. W., Venekamp, J. C., Falke, H. E., Noordhock, J., Blaauboer, B. J , and Wortelboer, H. W. Structure elucidation of acid reaction products of indole-3-carbinol, detection in vivo and enzyme induction in vitro. Chem.-Biol. Interact , 80, 303-315, 1991.
22. Bradfield, C. A., and Bjeldanes, L. F. High performance liquid chromatographic analysis of anticarcinogenic indoles in Brassica oleracea. J. Agric. Food Chem., 35 46-49, 1987.
23. Stresser, D M , Williams, D. E , and Bailey, G. S. Disposition and excretion of indole-3-carbinol (I3C) in Fisher 344 rats. Toxicologist. 13, 286, 1993.
24. Bradfield, C A., and Bjeldanes, L. F Effects of dietary indole-3-carbinol on intestinal and hepatic monooxygenase, glutathione-S-transferase, and epoxide hydrolase activities in the rat. Food Chem. Toxicol., 22, 977-992, 1984.
25. Chung, F. L., Juchatz, A., Vitarius, J. and Hecht, S. S Effects of dietary compounds on α-hydroxylation of N-nitrosopyrrolidine and N′-nitrosonornicotine in rat target tissues. Cancer Res., 44: 2924-2928, 1984.
26. Loub, W. D., Wattenburg, L. W., and Davis, P. W Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants J Natl Cancer Inst., 54: 985-988, 1975
27. Morse, M. A., LaGreca, S D., Amin, S. G , and Chung, F. L Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res., 50: 1613-1617, 1990.
28. Sparnius, V. L , Venegas, P. L., Wattenburg, L. W , and Davis, P. W. Glutathione S-transterase activity, enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer Inst., 68: 493-496, 1982.
29. Vang, O., Jensen, M. B., and Autrup, H. Induction of cytochrome P450 IA1 in rat colon and liver by indole-3-carbinol and 5,6-benzoflavone. Carcinogenesis (Lond), 11. 1259-1263, 1989.
30. Wattenburg, L. W , and Loub, W D. Inhibition of polycyclic aromatic hydrocarbon induced neoplasia by naturally occurring indoles. Cancer Res., 34: 1410-1413, 1978
31. Baldwin, W. S., and LeBlanc, G. A. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chem.-Biol. Interact., 83: 155-169, 1992.
32. Graham, S., Dayal, H , Swanson, M., Mittelman, A., and Wilkinson, G. Diet in the epidemiology of cancer of the colon and rectum. J. Natl Cancer Enst., 61: 709-714, 1978.
33. Marchand, L. L , Yoshizawa, C. N , Kolonel, L. N., Hankin, J. H., and Goodman, M. T. Vegetable consumption and lung cancer risk a population based case-control study in Hawaii. J. Natl. Cancer Inst., 81: 1158-1164, 1989.
34. Dunn, S E , and LeBlanc, G. A. Hypocholesterolemic properties of plant indoles Biochem. Pharmacol , 47: 359-364, 1994.
35. Marks, D. C., Belov, L , Davey, M W., Davey, R., and Kidman, A D. The MTT cell viability assay for cytotoxicity testing in multidrug resistant human leukemic cells Leukemia Res., 16: 1165-1173, 1992.
36. Mosman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol Methods, 65: 55-63, 1983.
37. Hamilton, M. A., Russo, R. C., and Thurston, R V Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Environ Sci. & Technol., 11: 714-719, 1978.
38. Egorin, M. J., Hildebrand, R. C., Cimino, E. F., and Bachur, N. R. Cytofluorescence localization of doxorubicin and daunorubicin. Cancer Res., 40: 2243-2245, 1974
39. Chieli, E., Santoni-Rugiu, E., Cervelh, F , Sabbatini, A., Petrini, M., Romiti, N , Paolicchi, A., and Tongiani, R. Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholanthrene in rat hepatocyte primary cultures Carcinogenesis (Lond), 15: 335-341, 1994.
40. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal. Biochem., 72 248-254, 1976.
41. 3H]methyltrienolone Biochem J., 288, 361-367, 1992.
42. Safa, A R. Photoaffinity labeling of P-glycoprotein in multidrug resistant cells Cancer Invest, 10: 295-305, 1992.
43. Yang, C. P., Mellado, W., and Horwitz, S B Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins Biochem Pharmacol., 37: 1417-1421, 1988
44. Dunnett, C. W A multiple comparisons procedure for comparing several treatments with a control. J. Am. Stat. Assoc., 50: 1096-1121, 1955.
45. Steel, R. G. D , and Torrie, J. H. Principles and Procedures of Statistics, pp 137-144. New York: McGraw-Hill, 1980.
46. Shertzer, H G., Niemi, M. P., Reitman, F. A., Berger, M. L , Myers, B. L , and Tabor, M. W. Protection against carbon tetrachloride hepatotoxicity by pretreatment with indole-3-carbinol. Exp. Mol Pathol , 46:180-189, 1987.
47. Shenzer, H G , Berger, M L., and Tabor, M. W. Intervention in free radical mediated hepatotoxicity and lipid peroxidation by indole-3-carbinol Biochem. Pharmacol., 37: 333-338, 1988.
48. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res , 41 1967-1972, 1981
49. Ozols, R F , Cunnion, R. E , Klecker, R W., Hamilton, T. C., Ostchega, Y., Parillo, J. E., and Young, R. C. Verapamil and doxorubicin in the treatment of drug-resistant ovarian cancer patients. J. Clin Oncol., 5, 641-647, 1987
50. Benson, A. B., Trump, D. L., Koeller, J. M., Egorin, M. I., Olman, E. A., and Witte, R. S. Phase I study of vinblastine and verapamil given by concurrent i.v. infusion. Cancer Treat. Rep., 69: 781-795, 1985.
51. Cantwell, B. M., Baumach, P., and Harris, A. L. Phase I and phase II study of oral verapamil (VPR) and intravenous vindesine (VDN). Proc Am. Soc. Clin. Oncol., 21: 42-49, 1985.
52. Tew, K. D., Houghton, P. J., and Houghton, J A. Modulation of P-glycoprotein-mediated multidrug resistance. In: M. A Hollinger (ed.), Preclinical and Clinical Modulation of Anti-Cancer Drugs, pp. 125-197. Boca Raton, FL: CRC Press, 1993.
53. LeBlanc, G. A., Smart, J. D., Dunn, S. E., and Baldwin, W. S. Effect of the plant compound indole-3-carbinol on hepatic cholesterol homeostasis. Food Chem. Toxicol., 32: 633-639, 1994.
54. Wortelboer, H. M., DeKruif, C A., Van Iersel, A. A., Falke, H. E., Noordhoek, J., and Blaauboer, B. J. Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes. Biochem. Pharmacol., 43: 1439-1447, 1992.